Home
About Us
Mission
Company Overview
Management
Board of Directors
Investors
R&D
Focus Areas
Dermatology
Endocrinology
Hematology
Neuromuscular
Orthopedics
Pipeline
PluraStem™
ImmuStem™
MesoStem™
AlloGraf™
GlucoStem™
MorphoGel™
Fibrostem™
Neurox™
OsteoStem™
Intellectual Property
Publications
Media
News Events
Press Releases
Careers
Openings
Benefits
EOE
How to Apply
Contact Us
Media
News Events
Press Releases
News Events
February 26, 2008
Escape closes Series A2 round.
Escape Therapeutics announces completion of its Series A2 round of financing.
